This is not a single article. It's every outletcovering this one event, gathered in one place — read AIPROPX's summary, see where the sources line up, then open any report at its origin.
By AIPROPX Editorial Desk · Published · Updated
Everything reported about this story, gathered from 3 sources. Read the summary below, then tap any source to open that report.

Johnson & Johnson's revenue has grown modestly while Eli Lilly's revenue has nearly doubled in two years, narrowing a once-wide gap.
Summary indexed by AIPROPX from The Motley Fool’s reporting — the full article is one click away. Open at source →
3 outlets are covering this. Resolve the ledger to read what they collectively report — the common thread, in plain terms.
Every report on this story — read the summary of each, then open any at its source. AIPROPX summarizes and links; it never reproduces the original.
Johnson & Johnson's revenue has grown modestly while Eli Lilly's revenue has nearly doubled in two years, narrowing a once-wide gap.
Read this report
Landmark deal covers about 76,000 claims and could end contentious, decade-long legal battle Johnson & Johnson said it would pay an estimated $5.5bn to resolve tens of thousands of lawsuits alleging its baby powder and other talc products caused ovarian cancer, in a landmark deal that could end a contentious, decade-long legal battle. Johnson & Johnson on Monday said the settlement covers about 76,000 claims, including ones consolidated in a federal court in New Jersey, and related cases in state court, representing nearly all of the remaining talc claims against the company. Continue r...
Read this reportAn original, deterministic readout — composed only from the computed coverage facts on this page. No interpretation, no rating; figures only.
AIPROPX has consolidated 3 reports from 3 outlets into a single canonical entry on “Johnson & Johnson to pay $5.5bn settlement in talc cancer lawsuit.” The covered outlets are based across 3 regions — Other, US, and UK.
The earliest report in this entry came from The Guardian US (Jul 28, 2026, 05:03 UTC); the most recent came from The Motley Fool (Jul 29, 2026, 11:24 UTC).
Comparing the wording across sources, 2 named entities are referenced by multiple outlets and the phrase recurring most across the coverage is “johnson johnson”.
3 statements are carried by only one outlet within this set and are not echoed by the others.
Every figure above is a direct count of real published articles. AIPROPX indexes and compares the original reporting — it never rewrites, rates, or editorializes — and each publisher’s full article is always one click away.
Generated by AIPROPX from the source counts above. AIPROPX indexes and resolves coverage; the original publishers are credited and linked at origin in every report.
Coverage from 3 independent outlets across 3 regions — each view opens on its own page.
AIPROPX — “Johnson & Johnson to pay $5.5bn settlement in talc cancer lawsuit” · https://www.aipropx.com/story/7ff14b6954434119d82572e45b622b46
Other events being covered across multiple sources right now.
EBays agreed to pay nearly $50 million to couple sent cockroaches, bloody pig mask
22 outletsFormer top US infectious disease expert Fauci declines to answer questions at Covid-19 hearing
14 outletsUefa accuses Fifa of ‘enriching themselves and their friends’ over World Cup sell-off
14 outletsUS bans new foreign-made robots
13 outletsJapan quake toll rises, people still missing in damaged mall and factory
12 outletsOil prices jump more than 7% after Trump says U.S. will hit Iran hard